|
US5149782A
(en)
*
|
1988-08-19 |
1992-09-22 |
Tanox Biosystems, Inc. |
Molecular conjugates containing cell membrane-blending agents
|
|
US5171563A
(en)
*
|
1988-09-30 |
1992-12-15 |
Neorx Corporation |
Cleavable linkers for the reduction of non-target organ retention of immunoconjugates
|
|
US5155210A
(en)
*
|
1990-09-11 |
1992-10-13 |
Brunswick Corporation |
Methods of conjugating actinomycin d
|
|
ATE152917T1
(de)
*
|
1990-09-28 |
1997-05-15 |
Neorx Corp |
Polymere träger zur freisetzung kovalent gebundener wirkstoffe
|
|
US5776458A
(en)
*
|
1990-12-05 |
1998-07-07 |
Pharmacia & Upjohn S.P.A. |
Anthracycline-conjugates
|
|
FR2676058B1
(fr)
*
|
1991-04-30 |
1994-02-25 |
Hoechst Lab |
Prodrogues glycosylees, leur procede de preparation et leur utilisation dans le traitement des cancers.
|
|
EP0752872B1
(en)
*
|
1994-04-05 |
2008-10-29 |
Morré, D. James |
Nadh oxidase as a target in diagnosis and therapy
|
|
US20030119724A1
(en)
*
|
1995-11-22 |
2003-06-26 |
Ts`O Paul O.P. |
Ligands to enhance cellular uptake of biomolecules
|
|
JP2001503396A
(ja)
*
|
1996-10-11 |
2001-03-13 |
アルザ コーポレイション |
治療用リポソーム組成物および方法
|
|
US6207805B1
(en)
|
1997-07-18 |
2001-03-27 |
University Of Iowa Research Foundation |
Prostate cell surface antigen-specific antibodies
|
|
US7157418B1
(en)
|
1998-07-22 |
2007-01-02 |
Osprey Pharmaceuticals, Ltd. |
Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
|
|
US20030215421A1
(en)
*
|
1999-07-21 |
2003-11-20 |
Mcdonald John R. |
Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
|
|
US6652836B2
(en)
|
1998-10-15 |
2003-11-25 |
Fluoroprobe, Inc. |
Method for viewing tumor tissue located within a body cavity
|
|
US6299860B1
(en)
*
|
1998-10-15 |
2001-10-09 |
Fluoro Probe, Inc. |
Method for viewing diseased tissue located within a body cavity
|
|
US7238368B2
(en)
|
1999-04-23 |
2007-07-03 |
Alza Corporation |
Releasable linkage and compositions containing same
|
|
WO2000064483A2
(en)
*
|
1999-04-23 |
2000-11-02 |
Alza Corporation |
Releasable linkage and compositions containing same
|
|
US7303760B2
(en)
|
1999-04-23 |
2007-12-04 |
Alza Corporation |
Method for treating multi-drug resistant tumors
|
|
CN100512879C
(zh)
|
1999-04-23 |
2009-07-15 |
阿尔萨公司 |
用于脂质体中的有可裂解键的缀合物
|
|
US7112337B2
(en)
|
1999-04-23 |
2006-09-26 |
Alza Corporation |
Liposome composition for delivery of nucleic acid
|
|
CN1110322C
(zh)
*
|
1999-07-21 |
2003-06-04 |
中国医学科学院医药生物技术研究所 |
单克隆抗体Fab'-平阳霉素偶联物及其抗肿瘤作用
|
|
WO2001062968A2
(en)
*
|
2000-02-25 |
2001-08-30 |
General Atomics |
Mutant nucleic binding enzymes and use thereof in diagnostic, detection and purification methods
|
|
WO2001071352A2
(en)
*
|
2000-03-17 |
2001-09-27 |
The Salk Institute For Biological Studies |
Compositions associated with complex formation
|
|
US6610504B1
(en)
|
2000-04-10 |
2003-08-26 |
General Atomics |
Methods of determining SAM-dependent methyltransferase activity using a mutant SAH hydrolase
|
|
EP1282714A2
(en)
*
|
2000-05-10 |
2003-02-12 |
Bristol-Myers Squibb Company |
Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof
|
|
US6906182B2
(en)
|
2000-12-01 |
2005-06-14 |
Cell Works Therapeutics, Inc. |
Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and method of use
|
|
PT1392359E
(pt)
|
2001-05-11 |
2010-01-27 |
Ludwig Inst For Cancer Res Ltd |
Proteínas de ligação específica e suas utilizações
|
|
US20100056762A1
(en)
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
|
NZ529788A
(en)
*
|
2001-05-31 |
2003-12-19 |
Medarex Inc |
Cytotoxins, prodrugs, linkers and stabilizers useful therefor
|
|
US7053188B2
(en)
|
2002-02-22 |
2006-05-30 |
Purdue Research Foundation |
Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase
|
|
US7384760B2
(en)
*
|
2004-04-30 |
2008-06-10 |
General Atomics |
Methods for assaying inhibitors of S-adenosylhomocysteine (SAH) hydrolase and S-adenosylmethionine (SAM)-dependent methyltransferase
|
|
US7691962B2
(en)
*
|
2004-05-19 |
2010-04-06 |
Medarex, Inc. |
Chemical linkers and conjugates thereof
|
|
EP1747021B1
(en)
*
|
2004-05-19 |
2015-09-09 |
E. R. Squibb & Sons, L.L.C. |
Self-immolative linkers and drug conjugates
|
|
US7541330B2
(en)
*
|
2004-06-15 |
2009-06-02 |
Kosan Biosciences Incorporated |
Conjugates with reduced adverse systemic effects
|
|
EP2266622A3
(en)
*
|
2004-08-26 |
2012-06-20 |
Piramal Life Sciences Limited |
Prodrugs containing novel bio-cleavable linkers
|
|
KR20070115967A
(ko)
*
|
2005-02-18 |
2007-12-06 |
메다렉스, 인코포레이티드 |
전립선 특이 막 항원(psma)에 대한 인간 모노클로날항체
|
|
US7714016B2
(en)
*
|
2005-04-08 |
2010-05-11 |
Medarex, Inc. |
Cytotoxic compounds and conjugates with cleavable substrates
|
|
EP1940470B1
(en)
*
|
2005-09-26 |
2013-04-17 |
Medarex, Inc. |
Antibody-drug conjugates and their use
|
|
EA015324B1
(ru)
|
2005-10-26 |
2011-06-30 |
Медарекс, Инк. |
Способы и соединения для получения аналогов сс-1065
|
|
WO2007059404A2
(en)
|
2005-11-10 |
2007-05-24 |
Medarex, Inc. |
Duocarmycin derivatives as novel cytotoxic compounds and conjugates
|
|
TWI412367B
(zh)
|
2006-12-28 |
2013-10-21 |
Medarex Llc |
化學鏈接劑與可裂解基質以及其之綴合物
|
|
ES2609094T3
(es)
|
2007-01-25 |
2017-04-18 |
Dana-Farber Cancer Institute, Inc. |
Uso de anticuerpos anti-EGFR en el tratamiento de enfermedades mediadas por un EGFR mutante
|
|
TW200900059A
(en)
*
|
2007-02-21 |
2009-01-01 |
Medarex Inc |
Chemical linkers with single amino acids and conjugates thereof
|
|
CA2680854C
(en)
|
2007-03-15 |
2017-02-14 |
Ludwig Institute For Cancer Research |
Treatment method using egfr antibodies and src inhibitors and related formulations
|
|
JP2010527618A
(ja)
|
2007-05-24 |
2010-08-19 |
アメリカ合衆国 |
ヌクレオシドサルベージ経路を通しての核内タンパク質伝達
|
|
EP2188311B1
(en)
|
2007-08-14 |
2016-10-05 |
Ludwig Institute for Cancer Research Ltd. |
Monoclonal antibody 175 targeting the egf receptor and derivatives and uses thereof
|
|
US20090304719A1
(en)
|
2007-08-22 |
2009-12-10 |
Patrick Daugherty |
Activatable binding polypeptides and methods of identification and use thereof
|
|
JP2010538798A
(ja)
*
|
2007-09-19 |
2010-12-16 |
オンコフルーア インコーポレイテッド |
臓器および組織を撮像および処置するための方法
|
|
WO2009151708A2
(en)
|
2008-05-27 |
2009-12-17 |
Genzyme Corporation |
Peptide analogs of alpha-melanocyte stimulating hormone
|
|
CA2745904C
(en)
|
2008-12-05 |
2014-07-08 |
Abraxis Bioscience Llc |
Sparc binding peptides and uses thereof
|
|
US20100189651A1
(en)
|
2009-01-12 |
2010-07-29 |
Cytomx Therapeutics, Llc |
Modified antibody compositions, methods of making and using thereof
|
|
WO2010096394A2
(en)
|
2009-02-17 |
2010-08-26 |
Redwood Biosciences, Inc. |
Aldehyde-tagged protein-based drug carriers and methods of use
|
|
EP2398494A4
(en)
|
2009-02-23 |
2015-10-28 |
Cytomx Therapeutics Inc |
Proproteins and their methods of use
|
|
WO2010138769A1
(en)
|
2009-05-28 |
2010-12-02 |
The United States Government As Represented By The Department Of Veterans Affairs |
Amino acid sequences which enhance peptide conjugate solubility
|
|
US8871744B2
(en)
|
2010-07-21 |
2014-10-28 |
B & G Partyers, LLC |
Compounds and methods for selectively targeting tumor-associated mucins
|
|
GB201012410D0
(en)
|
2010-07-23 |
2010-09-08 |
Medical Res Council |
Intracellular immunity
|
|
EP2663647A4
(en)
|
2011-01-14 |
2015-08-19 |
Redwood Bioscience Inc |
POLYPEPTIDE IMMUNOGLOBULINS WITH ALDEHYDIC MARKING AND THEIR USE METHOD
|
|
GB201202268D0
(en)
|
2012-02-09 |
2012-03-28 |
Medical Res Council |
Intracellular immunity
|
|
WO2014080251A1
(en)
|
2012-11-24 |
2014-05-30 |
Hangzhou Dac Biotech Co., Ltd. |
Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
|
|
AU2014384434B2
(en)
|
2014-02-28 |
2016-11-03 |
Hangzhou Dac Biotech Co., Ltd |
Charged linkers and their uses for conjugation
|
|
JP6921743B2
(ja)
|
2014-11-05 |
2021-08-18 |
ナンヤン テクノロジカル ユニヴァーシティー |
安定化かつ自律性抗体vhドメイン
|
|
JP6759326B2
(ja)
|
2015-07-12 |
2020-09-23 |
ハンジョウ ディーエーシー バイオテック シーオー.,エルティディ.Hangzhou Dac Biotech Co.,Ltd. |
細胞結合分子の共役のための架橋連結体
|
|
US9839687B2
(en)
|
2015-07-15 |
2017-12-12 |
Suzhou M-Conj Biotech Co., Ltd. |
Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
|
|
US11208632B2
(en)
|
2016-04-26 |
2021-12-28 |
R.P. Scherer Technologies, Llc |
Antibody conjugates and methods of making and using the same
|
|
CN109803687B
(zh)
|
2016-06-15 |
2022-11-15 |
耶鲁大学 |
纳米载体向肿瘤的抗体介导的自催化靶向递送
|
|
WO2017218824A1
(en)
|
2016-06-15 |
2017-12-21 |
Yale University |
Anti-guanosine antibody as a molecular delivery vehicle
|
|
CN110099682B
(zh)
|
2016-11-14 |
2023-03-31 |
杭州多禧生物科技有限公司 |
偶联连接体,含有此连接体的细胞结合分子-药物偶联物及其制备和应用
|
|
WO2019152806A1
(en)
|
2018-02-01 |
2019-08-08 |
Yale University |
Compositions and methods for enhancing nuclear translocation
|
|
WO2022013613A2
(en)
|
2020-07-17 |
2022-01-20 |
Onena Medicines S.L. |
Antibodies against lefty proteins
|
|
EP4079327A1
(en)
*
|
2021-04-22 |
2022-10-26 |
Centaurus Polytherapeutics |
Payloads for drug-conjugates and their use for treating cancer
|
|
WO2023010060A2
(en)
|
2021-07-27 |
2023-02-02 |
Novab, Inc. |
Engineered vlrb antibodies with immune effector functions
|
|
WO2023056450A1
(en)
|
2021-09-30 |
2023-04-06 |
Yale University |
Compositions and methods for the treatment of autosomal dominant polycystic kidney disease and other diseases having upregulated mtor activity
|
|
CN117980327A
(zh)
|
2021-11-03 |
2024-05-03 |
杭州多禧生物科技有限公司 |
抗体的特异性偶联
|
|
JP2025529210A
(ja)
|
2022-09-01 |
2025-09-04 |
ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド |
アポリポタンパク質l1を導いて哺乳動物の細胞死を誘導するための組成物及び方法
|
|
WO2024064752A2
(en)
|
2022-09-20 |
2024-03-28 |
Yale University |
Compositions of wet adhesives derived from vibrio cholerae biofilm adhesins and methods thereof
|
|
KR20250137203A
(ko)
|
2022-12-27 |
2025-09-17 |
예일 유니버시티 |
항체 약물 접합체
|
|
EP4655007A1
(en)
|
2023-01-23 |
2025-12-03 |
Yale University |
Antibody oligonucleotide conjugates
|
|
WO2024197302A1
(en)
|
2023-03-23 |
2024-09-26 |
Yale University |
Compositions and methods for delivering antibody oligonucleotide conjugates for exon skipping
|